All posts by: Michael Zand

About Michael Zand

‘Real World’ CAR T Cells: Comparing and Using Approved Products – Medscape

Continue reading

2018-02-02 NEWS

Medscape

‘Real World’ CAR T Cells: Comparing and Using Approved Products
Medscape
Miguel-Angel Perales, MD: Hello. I am Miguel Perales, deputy chief of the Adult Bone Marrow Transplant Center at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. Welcome to Medscape Oncology Insights, coming to you from the 2017

Continue reading

2018-02-02 NEWS

OncLive

Can Immunotherapy Bypass Sequential Care in RCC?
OncLive
McDermott outlined the potential for immunotherapy in RCC at the 2nd Annual International Congress on Immunotherapies in Cancer™, hosted by Physicians’ Education Resource®, LLC, in New York, New York, in December 2017. Despite positive clinical trial

Continue reading

2018-02-02 NEWS

William & Mary News

Likhitha Kolla ’18 awarded Thomas Jefferson Prize in Natural Philosophy
William & Mary News
She was a member of the 2016 iGEM team, which won a Gold Medal at an international syntheticbiology competition. Chancellor Professor of Biology Margaret Saha, faculty mentor to William & Mary’s iGEM team, says she’s a “huge fan of Likhitha

Continue reading

2018-02-02 NEWS

New Atlas

Double-barrel cancer treatment wipes out tumors and goes hunting for more
New Atlas
Harnessing the body’s natural immune defenses to take the fight to cancer, known as immunotherapy, is an especially promising area of cancer research with the potential to tackle all forms of the disease. Scientists from Stanford University are now
Injection helps the immune system obliterate tumors, at least in miceScience Magazine
Cancer breakthrough eliminates tumors in mice with simple injectionBGR
One injection could kill cancerMedical News Today
Medical Xpress –Stanford Medical Center Report –Science Translational Medicine –Stanford Profiles – Stanford University
all 105 news articles »